氯氮平与继发性抗体缺陷相关
本研究比较了服用氯氮平的精神分裂症患者与未服用氯氮平而使用其他抗精神病药的患者,发现氯氮平组免疫球蛋白水平显著降低,且一年内使用超过5个疗程抗生素的比例更高。抗体检测可能为氯氮平相关肺炎风险提供机制解释和可干预的风险因素。
要点
- 氯氮平治疗组免疫球蛋白IgG、IgA、IgM水平显著低于对照组。
- 氯氮平组免疫球蛋白低于第5百分位的比值比显著升高。
- 氯氮平使用时长与IgG下降相关,且抗生素使用比例更高。
核心结论
- 氯氮平使用与免疫球蛋白水平显著降低及一年内使用超过5个疗程抗生素的比例增加相关。
研究设计与样本
- 研究纳入服用氯氮平的患者(n=123)和未服用氯氮平而使用其他抗精神病药的患者(n=111),完成生活方式、药物和感染负担问卷,并检测血清总免疫球蛋白及特异性抗体。
主要发现
- 氯氮平治疗组免疫球蛋白(IgG、IgA、IgM)均显著低于未服用氯氮平组。
- 氯氮平组免疫球蛋白值低于第5百分位的比值比:IgG OR=6.00(95% CI 1.31-27.44);IgA OR=16.75(95% CI 2.18-128.60);IgM OR=3.26(95% CI 1.75-6.08)。
- 排除其他潜在低丙种球蛋白血症原因后,上述结果仍显著。
- 氯氮平使用时长与IgG下降相关。
- 氯氮平组报告一年内使用超过5个疗程抗生素的比例为5.3%(n=5),对照组为1%(n=1)。
临床怎么用
- 现有氯氮平监测方案未包含抗体检测,但抗体检测可能为肺炎和脓毒症相关死亡风险提供机制解释和可干预的风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly understood. AIMS: To investigate the potential association between clozapine and antibody deficiency. METHODS: Patients taking clozapine and patients who were clozapine-naive and receiving alternative antipsychotics were recruited and completed a lifestyle, medication and infection-burden questionnaire. Serum total immunoglobulins (immunoglobulin (Ig)G, IgA, IgM) and specific IgG antibodies to haemophilus influenzae type B, tetanus and IgG, IgA and IgM to pneumococcus were measured. RESULTS: Immunoglobulins were all significantly reduced in the clozapine-treated group (n = 123) compared with the clozapine-naive group (n = 111). Odds ratios (ORs) for a reduction in clozapine:control immunoglobulin values below the fifth percentile were IgG, OR = 6.00 (95% CI 1.31-27.44); IgA, OR = 16.75 (95% CI 2.18-128.60); and IgM, OR = 3.26 (95% CI 1.75-6.08). These findings remained significant despite exclusion of other potential causes of hypogammaglobulinaemia. In addition, duration on clozapine was associated with decline in IgG. A higher proportion of the clozapine-treated group reported taking more than five courses of antibiotics in the preceding year (5.3% (n = 5) versus 1% (n = 1). CONCLUSIONS: Clozapine use was associated with significantly reduced immunoglobulin levels and an increased proportion of patients using more than five antibiotic courses in a year. Antibody testing is not included in existing clozapine monitoring programmes but may represent a mechanistic explanation and modifiable risk factor for the increased rates of pneumonia and sepsis-related mortality previously reported in this vulnerable cohort. DECLARATION OF INTEREST: S.J. has received support from CSL Behring, Shire, LFB, Biotest, Binding Site, Sanofi, GSK, UCB Pharma, Grifols, BPL SOBI, Weatherden, Zarodex and Octapharma for projects, advisory boards, meetings, studies, speaker and clinical trials.
引用
- Ponsford M, Castle D, Tahir T, et al. Clozapine is associated with secondary antibody deficiency. Br J Psychiatry. 2018. PMID: 30259827. doi:10.1192/bjp.2018.152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。